- Home
- BVN vs VKTX Comparison
BVN vs VKTX Comparison
Compare BVN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVN
- VKTX
- Stock Information
- Founded
- BVN 1953
- VKTX 2012
- Country
- BVN Peru
- VKTX United States
- Employees
- BVN N/A
- VKTX N/A
- Industry
- BVN Metal Mining
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- BVN Basic Materials
- VKTX Health Care
- Exchange
- BVN Nasdaq
- VKTX Nasdaq
- Market Cap
- BVN 3.1B
- VKTX 2.8B
- IPO Year
- BVN 1996
- VKTX 2015
- Fundamental
- Price
- BVN $15.01
- VKTX $27.55
- Analyst Decision
- BVN Buy
- VKTX Buy
- Analyst Count
- BVN 2
- VKTX 12
- Target Price
- BVN $16.75
- VKTX $84.00
- AVG Volume (30 Days)
- BVN 1.1M
- VKTX 4.3M
- Earning Date
- BVN 05-01-2025
- VKTX 04-23-2025
- Dividend Yield
- BVN 1.86%
- VKTX N/A
- EPS Growth
- BVN 1928.16
- VKTX N/A
- EPS
- BVN 1.90
- VKTX N/A
- Revenue
- BVN $1,215,528,000.00
- VKTX N/A
- Revenue This Year
- BVN N/A
- VKTX N/A
- Revenue Next Year
- BVN N/A
- VKTX N/A
- P/E Ratio
- BVN $7.73
- VKTX N/A
- Revenue Growth
- BVN 40.15
- VKTX N/A
- 52 Week Low
- BVN $11.50
- VKTX $18.92
- 52 Week High
- BVN $18.84
- VKTX $81.81
- Technical
- Relative Strength Index (RSI)
- BVN 54.72
- VKTX 53.68
- Support Level
- BVN $14.67
- VKTX $26.37
- Resistance Level
- BVN $15.46
- VKTX $30.28
- Average True Range (ATR)
- BVN 0.51
- VKTX 1.65
- MACD
- BVN 0.05
- VKTX 0.27
- Stochastic Oscillator
- BVN 77.50
- VKTX 56.53
About BVN Buenaventura Mining Company Inc.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.